Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers.
about
Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster deliveryErythropoietin in Friedreich ataxiaFriedreich’s Ataxia Variants I154F and W155R Diminish Frataxin-Based Activation of the Iron–Sulfur Cluster Assembly ComplexStructure–Function Analysis of Friedreich’s Ataxia Mutants Reveals Determinants of Frataxin Binding and Activation of the Fe–S Assembly ComplexA combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial designPharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxiaDevelopment of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxiaGeneration and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell modelsDyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia.The in vivo mitochondrial two-step maturation of human frataxin.Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia.A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxiaFriedreich ataxia: failure of GABA-ergic and glycinergic synaptic transmission in the dentate nucleus.A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxiaFriedreich ataxia in Norway - an epidemiological, molecular and clinical studyNovel diagnostic paradigms for Friedreich ataxiaUnanswered questions in Friedreich ataxia.High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood.Management and therapy for cardiomyopathy in Friedreich's ataxia.Clinical features of Friedreich's ataxia: classical and atypical phenotypes.Friedreich Ataxia: current status and future prospects.Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9.FXN methylation predicts expression and clinical outcome in Friedreich ataxia.5q14.3 deletion manifesting as mitochondrial disease and autism: case report.Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.Frataxin silencing alters microtubule stability in motor neurons: implications for Friedreich's ataxia.The mitochondrial protein frataxin is downregulated in hemodialysis patients.An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levelsMolecular Diagnosis of Friedreich Ataxia Using Analysis of GAA Repeats andFXNGene Exons in Population from Western India
P2860
Q54838243-AF6145F2-24F0-482C-87CA-A055F02FAD3EQ54839004-C7407579-AF59-4271-BB65-E6C03C178450Q54842821-036C9621-33D8-482D-AE7E-E8F6AFCB3386Q54847196-7EDE92B1-929A-44D0-BA33-9D926F54AE78Q54847269-4ED63E03-51F3-4278-9C87-124BBFE1EA9FQ54847518-A8A6EC46-FBB3-482C-B4AE-14A39794FF71Q54848229-BFBB4418-FB63-4A76-8592-D916F1B4FF02Q54848230-E34A76DF-E0D8-4DBD-B73B-CDDB6F956D05Q54848231-E31CD9D2-AAE1-4768-B5FB-336152A7D0C9Q54848235-606F7F41-E7B8-4DEA-BE3F-8A3FCC7D5FB9Q54848366-EAFA442B-3269-4921-9EDE-36B61B7D7CB3Q54848379-64F46973-F257-4D89-A19F-3A9D13ED1C98Q54848381-1C2D86B2-C1EE-4B6C-A645-6EDC1F7CAD74Q54848384-666834D0-D561-4F0D-8184-23C6646C8858Q54848402-8CFE80B3-7431-4BB8-8FB5-16C2C3C04641Q54848403-54ABF5CA-DC54-4667-97DA-F7D26AF9443E
P1343
Q26850111-E1A89F38-E0BE-4BFA-B237-1C1811019D3CQ26863216-1971EF32-9ABC-4C79-9706-FAD2EDE6078FQ27670432-03E8EE3B-0427-4E12-9D51-DF7CD27E27B0Q27670917-ED5FF9B2-4C3C-4CEB-B386-712B470955D2Q28477407-38CC2126-F558-4404-8B6F-E3BA5F527C28Q28486160-37A25364-B63D-4B9A-8F48-10BFBE981181Q28488251-3C692D5E-21AE-42DC-A5ED-413B9529195CQ28540063-1A1B10E7-9755-4DFC-9BF0-A42CB26FAB80Q30602174-5AAC0625-A701-4467-A2F3-FFD0BD0A2B90Q33363024-7CB0D33D-A3A5-4484-9D69-6D196C794729Q34150158-38576605-1C22-4017-AE98-2D16790D0667Q34376985-F5F905DC-4AEB-413D-9131-08F186D72F57Q34964308-558E5548-AFD7-4D8A-9FA4-27857E95E842Q35144024-81660753-147B-4526-B28B-C7DA097D256AQ35764226-2F872D37-E750-4697-963E-6942B3FCBF45Q36907474-85CAF062-971D-435A-A7A7-5D92C65A58D5Q36907500-2E0915A5-CD76-4CDE-86DC-4E4056150F09Q37557229-9A442526-1724-4D4F-9703-4E0CD4EA5079Q38034809-9B177DA5-3656-4769-AA12-B3B6A052AD33Q38121948-9F2659F3-9125-478C-A55A-50D5D5D8389FQ38730963-8D9DB16F-871B-469A-8C47-987EDE017A33Q44407199-DF03263E-00A6-4B96-B09F-E10F623119D2Q47872898-F6D76833-C652-4060-8E42-1A1FF7DD9920Q50304932-3F4CA391-6C1B-4345-98EB-5122AD5F21FAQ51555749-C8204F6E-F560-461D-87B2-E4FFDABB98E1Q51575796-ECAC2638-44F1-4909-A39B-F8E6BD3E934CQ54282267-0D4F4303-5604-4E22-AE46-F15FB09DDE03Q57905710-A27D290B-A89A-4222-8995-255438121EABQ58920266-73905957-1C98-4A5B-9405-3D011805ADEE
P2860
Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@en
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@nl
type
label
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@en
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@nl
prefLabel
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@en
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@nl
P2093
P2860
P4510
P1476
Lateral-flow immunoassay for t ...... ataxia patients and carriers.
@en
P2093
Grazia Isaya
John H Willis
Michael F Marusich
Oleksandr Gakh
Roderick A Capaldi
P2860
P304
P356
10.1016/J.YMGME.2008.03.019
P577
2008-05-15T00:00:00Z